MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617064950 A) filed by Inflamax Pharmaceuticals Limited on May 22, 2026, for Novel Pace4 Inhibitor And Use Thereof In Anti-Osteoarthritis.
Inventors include Tortorella, Mickey Daniel; Chen, Longhui; and Zhang, Huatang.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: A novel PACE4 inhibitor and use thereof in anti-osteoarthritis. A novel PACE4 inhibitory peptide is designed and synthesized, which can effectively inhibit the expression of extracellular PACE4 without affecting normal cells, and is stable in joints and unstable in plasma, so that the PACE4 inhibitory peptide has excellent safety and can be effectively used in the prevention and treatment of OA.
Disclaimer: Curated by HT Syndication.
